Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
McCormick D
doi: 10.3389/FCIMB.2018.00011 72 VangTCongiaMMacisMDMusumeciLOrrVZavattariPet al
The reasoning follows a consistent framework
Special population studies, including evaluation in elderly patients, patients with significant comorbidities, and patients with organ dysfunction, would help establish safety profiles for diverse clinical populations
How well the treatment is working is checked by looking at blood counts and symptoms
82 Again, impressive outcome but there was no control group or blinding, so placebo effect or bias could explain some or all of the improvement
US$ 22.04
US$ 20.92
US$ 21.45
US$ 22.62
